|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-6-16
|
|
pubmed:abstractText |
• To investigate the potential beneficial effects of 4-week oral treatment with 5-cyclopropyl-2-[1-(2-fluoro-benzyl)-1Hpyrazolo[3,4-b]pyridin-3-yl]-pyrimidin-4-ylamine (BAY 41-2272), a nitric oxide (NO)-independent soluble guanylate cyclase activator, on impaired rat corpus cavernosum relaxations in NO-deficient rats.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1464-410X
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
108
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
116-22
|
|
pubmed:meshHeading |
pubmed-meshheading:20950311-Animals,
pubmed-meshheading:20950311-Cyclic GMP,
pubmed-meshheading:20950311-Enzyme Inhibitors,
pubmed-meshheading:20950311-Erectile Dysfunction,
pubmed-meshheading:20950311-Guanylate Cyclase,
pubmed-meshheading:20950311-Male,
pubmed-meshheading:20950311-Muscle Relaxants, Central,
pubmed-meshheading:20950311-NG-Nitroarginine Methyl Ester,
pubmed-meshheading:20950311-Nitric Oxide,
pubmed-meshheading:20950311-Penile Erection,
pubmed-meshheading:20950311-Pyrazoles,
pubmed-meshheading:20950311-Pyridines,
pubmed-meshheading:20950311-Rats,
pubmed-meshheading:20950311-Rats, Wistar
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Long-term oral treatment with BAY 41-2272 ameliorates impaired corpus cavernosum relaxations in a nitric oxide-deficient rat model.
|
|
pubmed:affiliation |
Department of Pharmacology, Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas (Sao Paulo), Brazil.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
